Paper9727961
Reduced level of plasma antioxidant uric acid in schizophrenia.
Yao JK and 2 others. Psychiatry Res, 1998. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Reduced level of plasma antioxidant uric acid in schizophrenia. Papers, record 9727961. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9727961
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Schizophrenia | Major topic |
| Uric Acid | Major topic |
| Adult | |
| Antioxidants | |
| Antipsychotic Agents | |
| Cotinine | |
| Haloperidol | |
| Humans | |
| Male | |
| Smoking |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42615015 | From Micro Molecular to Functional Levels Through Macro Structures: Mediation of Structural Brain Changes on the Relationship Between Oxidative Stress and Cognition in Early Onset Psychosis. | Schizophr Bull Open | 2026 | https://conductscience.org/library/papers/42615015 | PubMed |
| 41945311 | Glutathione deficiency in the early postnatal developmental period as a neurodevelopmental animal model of schizophrenia. | Pharmacol Rep | 2026 | https://conductscience.org/library/papers/41945311 | PubMed |
| 40278404 | Targeted and Non-Targeted Metabolomic Evaluation of Cerebrospinal Fluid in Early Phase Schizophrenia: A Pilot Study from the Hopkins First Episode Psychosis Project. | Metabolites | 2025 | https://conductscience.org/library/papers/40278404 | PubMed |
| 37032942 | Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/37032942 | PubMed |
| 36233136 | Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment? | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36233136 | PubMed |
| 36005598 | Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome. | Metabolites | 2022 | https://conductscience.org/library/papers/36005598 | PubMed |
| 35955425 | Antipsychotic Drug Aripiprazole Protects Liver Cells from Oxidative Stress. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955425 | PubMed |
| 35829960 | The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder. | CNS Drugs | 2022 | https://conductscience.org/library/papers/35829960 | PubMed |
| 35237183 | Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia. | Front Psychiatry | 2021 | https://conductscience.org/library/papers/35237183 | PubMed |
| 33837269 | Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway. | Mol Psychiatry | 2022 | https://conductscience.org/library/papers/33837269 | PubMed |
| 33828076 | Lithium: a potential therapeutic strategy in obsessive-compulsive disorder by targeting the canonical WNT/β pathway. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/33828076 | PubMed |
| 33278020 | Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. | Adv Ther | 2021 | https://conductscience.org/library/papers/33278020 | PubMed |
| 32993584 | Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study. | BMC Psychiatry | 2020 | https://conductscience.org/library/papers/32993584 | PubMed |
| 32686367 | Comparison of Serum Uric Acid in Major Depressive Disorder and Bipolar Disorder: a Retrospective Chart Review Study. | J Korean Med Sci | 2020 | https://conductscience.org/library/papers/32686367 | PubMed |
| 32161502 | Assessment Causality in Associations Between Serum Uric Acid and Risk of Schizophrenia: A Two-Sample Bidirectional Mendelian Randomization Study. | Clin Epidemiol | 2020 | https://conductscience.org/library/papers/32161502 | PubMed |
| 32095023 | Redox Is a Global Biodevice Information Processing Modality. | Proc IEEE Inst Electr Electron Eng | 2019 | https://conductscience.org/library/papers/32095023 | PubMed |
| 31354881 | Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia. | Cogn Neurodyn | 2019 | https://conductscience.org/library/papers/31354881 | PubMed |
| 28509906 | Therapeutic efficacy of atypical antipsychotic drugs by targeting multiple stress-related metabolic pathways. | Transl Psychiatry | 2017 | https://conductscience.org/library/papers/28509906 | PubMed |
| 28360631 | Are Uric Acid Levels Different from Healthy Subjects in Bipolar Affective Disorder and Schizophrenia?: Relationship Between Clinical Improvement and Episode Severity in Male Patients. | Noro Psikiyatr Ars | 2014 | https://conductscience.org/library/papers/28360631 | PubMed |
| 26405388 | Oxidative Stress-Induced Response of Some Endogenous Antioxidants in Schizophrenia. | Indian J Clin Biochem | 2012 | https://conductscience.org/library/papers/26405388 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9727961
GET https://conductscience.org/api/papers/v1/9727961/cited_by?page=2